isospaglumic acid has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alt, J; Hollinger, KR; Kaplin, AI; Riehm, AM; Slusher, BS | 1 |
| Alt, J; Barker, PB; Brandt, J; Calabresi, PA; Crainiceau, CM; Grishkan, I; Kaplin, AI; Pletnikov, MV; Pomper, MG; Rahn, KA; Rais, R; Rojas, C; Slusher, BS; Stathis, M; Watkins, CC | 1 |
2 other study(ies) available for isospaglumic acid and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis.
Topics: Animals; Aspartic Acid; Cognition Disorders; Dipeptides; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Female; Glutamate Carboxypeptidase II; Hippocampus; Maze Learning; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Organophosphorus Compounds; Severity of Illness Index | 2016 |
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Topics: Adult; Analysis of Variance; Animals; Cognitive Dysfunction; Dipeptides; Encephalomyelitis, Autoimmune, Experimental; Female; Flow Cytometry; Glutamate Carboxypeptidase II; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuropsychological Tests; Organophosphorus Compounds | 2012 |